Frequently Asked Questions
The market is segmented based on , By Product (Enzymes, Instruments and Consumables, Kits, and Reagents), Application (Oncology and Non-Oncology), Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large non-coding RNA, MicroRNA modification, and Chromatin structures), End User (Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, and Contract Research Organizations (CROs)) – Industry Trends and Forecast to 2031.
.
The Global Epigenetics Market size was valued at USD 15.83 USD Billion in 2023.
The Global Epigenetics Market is projected to grow at a CAGR of 20.2% during the forecast period of 2024 to 2031.
The major players operating in the market include Illumina , Merck KGaA, QIAGEN, F. Hoffmann-La Roche Ltd, Eisai Co. , Novartis AG, and more .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
